WIN Consortium
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval
2015 · Denis L. Jardim, Maria Schwaederlé, et al. · JNCI Journal of the National Cancer Institute
Clinical trial design in the era of precision medicine
2022 · Elena Fountzilas, Apostolia M. Tsimberidou, et al. · Genome Medicine
The coming decade in precision oncology: six riddles
2022 · Adam Wahida, Lars Buschhorn, et al. · Nature reviews. Cancer